Age (y)
|
0.96 (0.93–0.99)
|
0.003
| | | | |
Male sex
|
0.82 (0.35–1.95)
|
0.655
| | | | |
Cardiac arrest witnessed
|
1.07 (0.48–2.38)
|
0.876
| | | | |
Bystander CPR attempt
|
2.70 (1.20–6.06)
|
0.016
| | | | |
Initial recorded cardiac arrest rhythm
| | |
0.62 (0.42–0.93)
|
0.02
|
0.63 (0.42–0.95)
|
0.028
|
VF or pulseless VT
|
0.78 (0.28–2.19)
|
0.641
| | | | |
Pulseless electrical activity
|
0.96 (0.28–3.36)
|
0.954
| | | | |
Asystole
|
1.000 (ref.)
|
0.850
| | | | |
Gasping during transportation by EMS
|
8.37 (3.64–19.27)
|
<.001
|
9.52 (5.31–17.08)
|
< .001
|
9.94 (5.49–18.00)
|
< .001
|
Aetiology of cardiac arrest
|
0.59 (0.25–1.38)
|
0.225
| | | | |
Epinephrine dose before hospital admission, mg
|
0.70 (0.54–0.92)
|
0.009
| | | | |
Cardiac rhythm at admission
|
ROSC
|
8.25 (1.58–43.13)
|
0.012
| | | | |
VF or pulseless VT
|
1.77 (0.54–5.79)
|
0.344
| | | | |
Pulseless electrical activity
|
0.72 (0.18–2.80)
|
0.633
| | | | |
Asystole
|
1.000 (ref.)
|
0.013
| | | | |
Low-flow duration, min
|
0.98 (0.95–1.00)
|
0.075
|
0.99 (0.97–1.01)
|
0.34
|
0.99 (0.97–1.01)
|
0.510
|
No-flow duration, min, n = 115b
|
0.88 (0.80–0.98)
|
0.018
| | | | |
pH at admission, n = 162c
|
9.88 (0.77–127.38)
|
0.079
| | | | |
Serum lactate value at admission, n = 158c
|
1.01 (0.93–1.10)
|
0.783
| | |
1.03 (0.97–1.09)
|
0.399
|
Epinephrine administration after admission, mg
|
0.76 (0.57–1.02)
|
0.070
| | | | |
Intra-aortic balloon pumping
|
1.36 (0.59–3.17)
|
0.471
| | | | |
Percutaneous coronary intervention
|
0.94 (0.44–1.98)
|
0.865
| | | | |
Therapeutic temperature management
|
1.62 (0.70–3.74)
|
0.261
| | | | |